Orchid Island Capital, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Orchid Island Capital, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.03M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $37.66M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | ($39.23M) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | ($258.45M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | ($64.76M) | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $16.48M | Mar 15, 2021 |
| FY2020 | Sep 30, 2020 | $28.08M | Mar 15, 2021 |
| FY2020 | Jun 30, 2020 | $48.77M | Mar 15, 2021 |
| FY2020 | Mar 31, 2020 | ($91.20M) | Mar 15, 2021 |
| FY2020 | Dec 31, 2019 | $18.61M | Mar 15, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $15.25M | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | $10.54M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $10.39M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $11.96M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $11.17M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $9.09M | Feb 22, 2019 |
| FY2017 | Dec 31, 2015 | $7.89M | Feb 15, 2018 |
| FY2014 | Dec 31, 2014 | $1.45M | Feb 24, 2015 |
| FY2014 | Sep 30, 2014 | $1.39M | Feb 24, 2015 |
| FY2014 | Jun 30, 2014 | $1.12M | Feb 24, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.45M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $66.99M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $8.00M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $289.37M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $96.44M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $55.37M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $48.16M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $94.00M | Mar 15, 2021 |
| FY2016 | Dec 31, 2016 | $47.05M | Feb 17, 2017 |
| FY2016 | Dec 31, 2015 | $30.71M | Feb 17, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.68B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $5.72B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $4.26B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.87B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $7.07B | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $4.06B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $3.88B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $3.40B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $4.02B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $3.14B | Feb 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.30B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $5.05B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.80B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.43B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $6.30B | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $3.64B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $3.49B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $3.06B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $3.56B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.81B | Feb 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.37B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $668.50M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $469.95M | Feb 20, 2026 |
| FY2025 | Dec 31, 2022 | $438.76M | Feb 20, 2026 |
| FY2024 | Dec 31, 2021 | $768.10M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $415.29M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $395.51M | Mar 3, 2023 |
| FY2021 | Dec 31, 2018 | $336.08M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $462.21M | Mar 15, 2021 |
| FY2019 | Dec 31, 2016 | $332.78M | Feb 21, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($183.74M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($342.77M) | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | ($380.43M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | ($341.21M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($82.75M) | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | ($17.99M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($20.12M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($44.39M) | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $0 | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Feb 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $665.87M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $309.33M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $171.89M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $205.65M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $385.14M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $220.14M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $193.77M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $108.28M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $214.36M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $73.48M | Feb 15, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | (6) | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 3, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Mar 31, 2020 | (1) | Mar 15, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 15, 2021 |
| FY2020 | Sep 30, 2019 | 0 | Mar 15, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Mar 15, 2021 |
| FY2020 | Mar 31, 2019 | 0 | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Feb 21, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 21, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 181.99M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 82.62M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 51.64M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 36.76M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 35.40M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | 76.07M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | 63.06M | Feb 25, 2022 |
| FY2021 | Dec 31, 2018 | 49.13M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | 53.06M | Mar 15, 2021 |
| FY2019 | Dec 31, 2016 | 32.96M | Feb 21, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $178.86M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $92.50M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $80.75M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $93.49M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $90.98M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $53.65M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $53.31M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $59.31M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $67.90M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $36.77M | Feb 22, 2019 |